PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System (NCT06054867)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (8 items).
Location: University of Southern California, Institute of Urology — Los Angeles, California
Age range: 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Any prior or current treatment for prostate cancer, including but not limited to surgery, radiation therapy (external or brachytherapy), tissue ablation or chemotherapy.
- Patients with previous surgical or minimally invasive treatment of benign prostatic hyperplasia within the prior 12 months.
- Radiographically suspicious lymph node involvement confirmed with biopsy or PET scan.
- Evidence of bone metastasis.
- Evidence of extracapsular involvement.
- Evidence of seminal vesicle invasion on DRE or MRI read as "definite", "probable" or "consistent with"
- Any condition or history of illness or surgery that may pose an additional risk to men undergoing the Aquablation procedure.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (3 Sites)
- University of Southern California, Institute of Urology — Los Angeles, California
- NorthShore University HealthSystem — Glenview, Illinois
- NYU Grossman School of Medicine — New York, New York
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Localized Prostate Cancer
- 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy — Bethesda, Maryland
- WATER IV PCa (AS Sub-study) — Chandler, Arizona
- Sonablate HIFU International Registry for PC & BPH Patients — Indianapolis, Indiana
- Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer. — New York, New York
- Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE) — Toronto, Ontario
Explore by condition: All Localized Prostate Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.